Engineering human stellate cells for beta cell replacement therapy promotes in vivo recruitment of regulatory T cells

Type 1 diabetes (T1D) is an autoimmune disease characterized by destruction of pancreatic β cells. One of the promising therapeutic approaches in T1D is the transplantation of islets; however, it has serious limitations. To address these limitations, immunotherapeutic strategies have focused on rest...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mater Today Bio
Autors principals: Oran, D.C., Lokumcu, T., Inceoglu, Y., Akolpoglu, M.B., Albayrak, O., Bal, T., Kurtoglu, M., Erkan, M., Can, F., Bagci-Onder, T., Kizilel, S.
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2019
Matèries:
Full-Length Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7061575/
https://ncbi.nlm.nih.gov/pubmed/32159143
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mtbio.2019.100006
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars